[(4-[(S)-2-ACETYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-(DIETHOXYPHOSPHORYL)-METHYL]-PHOSPHONIC-ACID-DIETHYLESTE
Compound with spectra: 1 NMR
![[(4-[(S)-2-ACETYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-(DIETHOXYPHOSPHORYL)-METHYL]-PHOSPHONIC-ACID-DIETHYLESTE](/api/compound/DMy8AcE5sQa.png?ph=true&h=300&w=458 "[(4-[(S)-2-ACETYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-(DIETHOXYPHOSPHORYL)-METHYL]-PHOSPHONIC-ACID-DIETHYLESTE")
| SpectraBase Compound ID | DMy8AcE5sQa |
|---|---|
| InChI | InChI=1S/C36H55N3O10P2/c1-7-46-50(43,47-8-2)36(51(44,48-9-3)49-10-4)29-18-16-27(17-19-29)22-32(39-26(6)40)35(42)38-25(5)30-20-21-33(31(23-30)34(37)41)45-24-28-14-12-11-13-15-28/h16-21,23,25,28,32,36H,7-15,22,24H2,1-6H3,(H2,37,41)(H,38,42)(H,39,40)/t25-,32-/m0/s1 |
| InChIKey | HWHADWDGUIGLTE-UKJJDJLKSA-N |
| Mol Weight | 751.8 g/mol |
| Molecular Formula | C36H55N3O10P2 |
| Exact Mass | 751.336269 g/mol |
| Enantiomer InChIKey | HWHADWDGUIGLTE-NLGDKJDOSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenyl-N-[1-(5,6,7,8-tetrahydro-2-naphthalenyl)ethyl]propanamide
2-HYDROXY-5-(5-NITRO-1H-IMIDAZOL-2-YL)-BENZOYL-ISOLEUCYL-TYROSINE-METHYLESTER
Methyl 1-(8-(4-[(ethoxycarbonyl)amino]butyl)-2-(4-[(ethoxycarbonyl)oxy]benzyl)-5,11-diisopropyl-4,7,10,13-tetraoxo-14-oxa-3,6,9,12-tetraazahexadec-1-anoyl)-2-pyrrolidinecarboxylate
(3SR,6SR)-3-(2,4,5-Trimethoxy-3-methylbenzyl)-1,6-dimethylpiperazine-2,5-dione
L-Proline, 1-[O-(1-oxohexyl)-N-[N-[N6-(1-oxohexyl)-N2-[N-(1-oxohexyl)-L-valyl]-L-lysyl]-L-valyl]-L-tyrosyl]-, methyl ester
N(2,2)-[(S)-N(2,1)-Benzoyl-2-phenyl-2-allylglycyl]-L-phenylalanyl-L-phenylalanine-dimethylamide
(3S,11aS)-3-(2-methylpropyl)-3,6,11,11a-tetrahydro-2H-pyrazino[1,2-b]isoquinoline-1,4-dione
FEGLYMYCIN
benzoic acid, 3-[[(2S)-2-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-1-oxo-3-phenylpropyl]amino]-, ethyl ester
(E)-(3S,6R,10R,16S)-10-(3,5-Dichloro-4-hydroxy-benzyl)-3-isobutyl-6-methyl-16-[(S)-1-((2R,3R)-3-phenyl-oxiranyl)-ethyl]-1,4-dioxa-8,11-diaza-cyclohexadec-13-ene-2,5,9,12-tetraone
| Title | Journal or Book | Year |
|---|---|---|
| X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor | Journal of Medicinal Chemistry | 2001 |